HLMNX | VTISX | HLMNX / VTISX | |
Total Expense Ratio | 1.15 | 0.05 | 2,300% |
Annual Report Gross Expense Ratio | 1.15 | 0.05 | 2,300% |
Fund Existence | 20 years | 9 years | - |
Gain YTD | 6.069 | 5.652 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 3000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.1B | 453B | 3% |
Annual Yield % from dividends | 1.61 | 3.17 | 51% |
Returns for 1 year | 0.92 | 4.87 | 19% |
Returns for 3 years | -0.27 | 6.25 | -4% |
Returns for 5 years | 47.67 | 60.44 | 79% |
Returns for 10 years | 52.51 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
WDNA | 12.75 | 0.26 | +2.07% |
WisdomTree BioRevolution ETF | |||
TSPA | 35.58 | 0.29 | +0.82% |
T. Rowe Price US Equity Research ETF | |||
LCF | 35.31 | 0.27 | +0.77% |
Touchstone US Large Cap Focused ETF | |||
RSPU | 70.32 | 0.37 | +0.53% |
Invesco S&P 500® Equal Weight Utilts ETF | |||
DFE | 61.18 | 0.28 | +0.46% |
WisdomTree Europe SmallCap Dividend ETF |